Charles Schwab Investment Management »

Rapt Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Rapt Therapeutics (RAPT) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Rapt Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapt Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapt Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 236k 8.98
2023-12-31 $5.8M 234k 24.85
2023-09-30 $3.7M 222k 16.62
2023-06-30 $3.7M 198k 18.70
2023-03-31 $3.6M 195k 18.35
2022-12-31 $3.4M 171k 19.80
2022-09-30 $4.0M 167k 24.06
2022-06-30 $2.8M 152k 18.25
2022-03-31 $3.2M 146k 21.99
2021-12-31 $5.2M 142k 36.73
2021-09-30 $4.4M 140k 31.06
2021-06-30 $2.6M 81k 31.80
2021-03-31 $1.5M 66k 22.21
2020-12-31 $1.3M 66k 19.76
2020-09-30 $2.1M 65k 32.20
2020-06-30 $1.5M 52k 29.02
2020-03-31 $631k 30k 21.29
2019-12-31 $448k 16k 27.66